Member Info for PhatStyle4321

I have a strong feeling the results will be coming this week, if positive, are we saying £3 open?

It’s a better risk to reward than this, just keeps heading lower

https://www.londonstockexchange.com/news-article/market-news/nestle-commences-tender-offer-aimmune-therapeutics/14683967

Easily could be an offer at anytime, RNS expected this week

If positive news drops Monday which is very likely, today will be the last chance to get your hands on 4D

Just an observation, but the placing which was undertook by all of the directors was after the interim results of Blautix, therefore if Duncan and Alex stuck another £200,000 in, after seeing the results, they were probably very confident that Blautix final results were going to be good. I have nothing confirming this as its all in the RNS's but just an observation

Next week is looking like news week !!!

All you need to look at is companies that do a similar thing, look at Seres Therapeutics they are worth $2.2 billion, only a fraction of what we are worth. IBS treatment is a huge problem and I think 4D have a cure, these shares are extremely cheap.

£2.50 is my target when news is released

Today could be the last day to get some before the Blautix news, this will be the first Phase 2 results and if it’s positive £1.30’s will be long gone, and £2.50’s will be insight. Merk will probably bid for the whole company and patent rights

Looks like the big news next week, which is my preference, should be back over £1.30 today, can’t see any other stock being more exciting that 4D Pharma, all of the pain and hard work is starting to reep all the benefits

Top line results are anticipated by the end of September, an email from the company also confirms that they are on target to release this information, however there have been patients who were on the trial reporting excellent results, but can confirm how reliable results will be. If you look at the Phase 1 and interim results of Blautix the results were extremely promising, just hope it was replicated over a larger sample size

Once phase 2 results hit and if they are what we expect, this is going to explode!! I can’t imagine all of the potential, especially coupled with the cancer data, no wonder Duncan has put so much of his money in because it really is a winner

More volume will be moving here in the next week or so, anticipation is extremely high and this company has so much potential £3 by Christmas

This will continue our rising trend, there must be so much data to extrapolate and news could come anytime, i for one would not like to be out. Blautix will be a game changer for IBS treatment, that alone will give 4D over a £1 billion valuation, looks Iike all Pharmas going to list on Nasdaq

We should be back to over £1.30 by end Friday, all market volatility going back to normal

Results are coming anyday now and when do come, this will rocket and it will be out of the £1's and straight to the £2's, so undervalued at the moment

Confirmation of the read out to occur by end of Q3, therefore these results could land any day till the end of September and I wouldn't to be out of this when they do. Blautix is going to be a game changer if positive and the directors wouldn't have invested so much if they thought it was going to fail. £5 target price

One RG is out, this will motor he can’t have many left, and the buying pressure has returned

This is just market makers playing their games to offload all the shares they had accumulated, the story on 4D hasn’t changed at all. A lot of stops got taken out yesterday and it will be a nice recovery upwards. We can be up 30-40% in one day. Any takeover RNS or Blautix update will send this sky high

One of the main strengths to all of 4D’s products is the safety profile and how safe our treatments are. The fact the vaccine has been paused due to an adverse reaction highlights just how undervalued this company is.

https://www.google.co.uk/amp/s/news.sky.com/story/amp/coronavirus-oxford-vaccine-trial-put-on-hold-as-volunteer-suffers-suspected-serious-adverse-reaction-12066991